Skip to main content
Equibles

IMC-Chicago, LLC

Position in TLRY — Tilray Brands, Inc.

CIK 1452861 CHICAGO, IL
Back to TLRY Full portfolio

Position in TLRY

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$80,837
-$349,111 QoQ
Shares Held
18,004
-27.6% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#77
of 235 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TLRY Over Time

Shares Held

Position Value (USD)

Derivatives in TLRY

reported options exposure · as of Sep 30, 2021
CallValue
$13,249,944
CallShares
117,360
PutValue
$8,889,746
PutShares
78,740

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

IMC-Chicago, LLC holds $58,181,394 across 12 Drug Manufacturers - Specialty & Generic names. TLRY ranks #11 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HIMS
Hims & Hers Health, Inc.
 789,513 $27,372,415
2 BCRX
Biocryst Pharmaceuticals Inc
 1,634,336 $16,343,360
3 ZTS
Zoetis Inc.
 67,756 $4,868,946
4 UTHR
UNITED THERAPEUTICS Corp
 6,521 $3,533,273
5 TEVA
Teva Pharmaceutical Industries Ltd
 36,515 $1,237,128
6 PRGO
PERRIGO Co plc
 111,868 $1,162,308
7 LNTH
Lantheus Holdings, Inc.
 10,061 $1,116,167
8 ALKS
Alkermes plc.
 20,383 $1,068,069

All Filings in TLRY

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $80,837 18,004
2025-09-30 $429,948 248,525
2024-12-31 $434,750 326,880
2024-09-30 $342,082 194,365
2023-03-31 $225,268 89,039
2022-03-31 $2,410,790 310,269
2021-09-30 $13,249,944 1,173,600
2021-09-30 $8,889,746 787,400
2021-09-30 $380,822 33,731
2021-03-31 $897,675 39,493